Charles, Julie <br/><br/>
T-cell receptor diversity as a prognostic biomarker in melanoma patients.  [electronic resource] 

 -  Pigment cell & melanoma research  07 2020 
 - 612-624 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1755-148X 
<br/><br/><label>Standard No.: </label>10.1111/pcmr.12866  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Biomarkers, Tumor--genetics<br/>Cohort Studies<br/>Disease-Free Survival<br/>Female<br/>Genetic Variation<br/>Humans<br/>Lymph Nodes--pathology<br/>Lymphatic Metastasis--pathology<br/>Lymphocyte Count<br/>Male<br/>Melanoma--blood<br/>Middle Aged<br/>Prognosis<br/>Receptors, Antigen, T-Cell--genetics<br/>Skin Neoplasms--blood<br/>Treatment Outcome